21 October 2020 · Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Monamine-oxidase inhibitors (MAOIs) Due to the…

22 May 2020 · This Medicines Q&A outlines the causes and symptoms of serotonin syndrome and provides examples of medicines with the potential to cause serotonin syndrome.  

5 February 2020 · This Medicine Q&A gives details of available urinary frequency, enuresis, incontinence and urinary retention preparations that do not contain lactose. There is a lactose-free preparation…

21 October 2019 · This updated Medicines Q&A provides advice on the risks and suggested strategies for switching between tricyclic (TCA), selective serotonin reuptake inhibitors (SSRI) and related antidepressants.…

24 September 2019 · This Medicine Q&A lists currently available lactose-free antidepressant preparations. There is a lactose-free preparation available for all antidepressants except for clomipramine, doxepin, isocarboxazid, moclobemide, nortriptyline…

10 June 2019 · This Medicines Q&A evaluates the evidence available on the management of depression in patients with antidepressant-induced hyponatraemia. Summary Most antidepressants are associated with hyponatraemia, with…

29 January 2019 · NICE recommend that non-pharmacological interventions such as CBT should be considered in people presenting with depression, in addition to the use of antidepressants. With respect…

2 October 2018 · This updated Q&A describes the limited data on antidepressant use in patients with coronary heart disease.